PA
CDNA icon

Parallel Advisors’s CareDx CDNA Stock Holding History

Parallel Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9
Closed -$160 – 3567
2025
Q1 		$160 Hold
9
– – ﹤0.01% 3410
2024
Q4 		$193 Buy
+9
New +$219 ﹤0.01% 3376
2023
Q3 		– Sell
-11
Closed -$94 – 3383
2023
Q2 		$94 Sell
11
-225
-95% -$1.88K ﹤0.01% 3290
2023
Q1 		$2.16K Sell
236
-40
-14% -$512 ﹤0.01% 2746
2022
Q4 		$3.15K Buy
276
+165
+149% +$2.44K ﹤0.01% 2508
2022
Q3 		$2K Buy
111
+3
+3% +$64 ﹤0.01% 2609
2022
Q2 		$2K Buy
108
+87
+414% +$2.41K ﹤0.01% 2548
2022
Q1 		$1K Hold
21
– – ﹤0.01% 2709
2021
Q4 		$1K Sell
21
-23
-52% -$1.2K ﹤0.01% 2842
2021
Q3 		$3K Buy
44
+15
+52% +$1.14K ﹤0.01% 2548
2021
Q2 		$3K Hold
29
– – ﹤0.01% 2438
2021
Q1 		$2K Buy
+29
New +$2.25K ﹤0.01% 2449

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Parallel Advisors's CDNA Position: Q2 2025 in Review

Parallel Advisors sold out of CareDx (CDNA) in Q2 2025, closing a stake of 9 shares — an estimated $160 sold.

Parallel Advisors first reported a position in CDNA in Q1 2021 and held it in 12 quarters. The position peaked at $3.15K in Q4 2022. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Parallel Advisors reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Parallel Advisors sold 9 CareDx shares in Q2 2025, an estimated $160.
  • Parallel Advisors first reported a position in CareDx in Q1 2021 and held it in 12 quarters.
  • Parallel Advisors's CareDx position peaked at $3.15K in Q4 2022.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.